Amgen Inc (AMGN)

[TREND1]

Confidential Treatment Order (ct Order)

Date : 05/26/2017 @ 9:49AM
Source : Edgar (US Regulatory)
Stock : Amgen Inc. (MM) (AMGN)
Quote : 154.03 -0.98 (-0.63%) @ 3:38PM

[TREND1]

DEW here is exact post
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131759835

[TREND1]

SEE MNKD BOARD
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131763466

[DewDiligence]

First I've heard of that notion. Where did it come from?

[TREND1]

Dew Do you see AMGN taking over MNKD ?
New CEO is from AMGN.

[TREND1]

FLOAT= 735.16M

[TREND1]

PE = 15.1

[TREND1]

EPS = 10.32

[TREND1]

AMGN

[DewDiligence]

AMGN offers “money-back” pricing on Repatha for US payers: #msg-129644848.

[DewDiligence]

The Appellate Court stayed the decision pending appeal, so SNY/REGN can continue to sell Praluent.

[trendmkr]

Regeneron Pharmaceuticals And Sanofi Loses On A Suit Blocking Amgen From Selling Cholesterol Drug https://marketexclusive.com/regeneron-pharmaceuticals-inc-nasdaqregnand-sanofi-sa-adrnysesny-loses-suit-blocking-amgen-inc-nasdaqamgn-selling-cholesterol-drug/71476/?icd1

[ValueInvestor15]

5yr DCF imply Amgen Inc $AMGN is 20% undervalued w/ earnings expected Thursday:

DCF Analysis

[DewDiligence]

FDA approves AMGN’s Humira biosimilar:

#msg-125360154 (PR)
#msg-125362246 (musings)

[Diogenes of Sinope]

AMGN---GLTA!

[JefftDecker]

AMGN

looking interesting here, awhile back a sharp option trader bought
2000 Oct 21- 170 calls for $5.60@ your talking 1.12 million $ here.

does he know something?

I may do some of this trade fwiw

good trades

[DewDiligence]

AMGN/AGN report phase-3 data for Herceptin FoB: #msg-124404733.

[DewDiligence]

It's a small risk for AMGN, since the money is heavily backloaded. I commented on ADXS' CC: #msg-124267344. Regards, Dew

[gccarlin99]

Any thoughts on the Advaxis deal?

[TREND1]

AMGN DAY

[TREND1]

AMGN DAY

[TREND1]

Short % of Float = 1.19%

[TREND1]

Inst % Owned = 88%

[TREND1]

EPS = 9.15

[TREND1]

AMGN DAY

[stocktrademan]

AMGN bullish 163.03

[ITMS]

This Bounce Has Serious Legs: $AMGN

Over the course of June, Amgen, Inc. (NASDAQ:AMGN) fell nearly every day. The stock traded as high as $161.00 in early June before falling to a low yesterday of $144.00. This was a 10.55% drop. For a stock this big, that is an epic fall for a one month period.

While many investors are scared to go near Amgen, the best time to buy is where there is blood in the street. The key is finding a legitimate reason. The reason comes to the forefront when looking at the chart below. There is a major trend line tagged yesterday. The stock is already bouncing 1.58% today, but has more room to run. An upside bounce in a week or two will likely net a move to $152.25.



Gareth Soloway
InTheMoneyStocks

[0dd Lot]

The Big Short's Dr. Michael Burry goes long on Amgen in Q1

http://whalewisdom.com/filer/scion-asset-management-llc#/tabholdings_tab_link

One of only 8 positions, the 40,000 shares represent ~12% of Scion's portfolio. During Q1, the stock traded from $141-$158.

[$Pistol Pete$]

$AMGN Daily and Weekly Charts

[nyctraydr]

Who Would Make a Good Suitor for Shield Therapeutics? - article mentions Amgen http://marketexclusive.com/who-would-make-a-good-suitor-for-shield-therapeutics/2906/

[$Pistol Pete$]

$AMGN Daily Chart

[venturecapp]

Dermira Targets a Billion Dollar Opportunity -article mentions Amgen

http://marketexclusive.com/off-the-radar-dermira-targets-a-billion-dollar-opportunity/1678/

[trendmkr]

Is Guardant Next in Line for a Big Pharma Suitor? - article mentions Amgen

http://marketexclusive.com/is-guardant-next-in-line-for-a-big-pharma-suitor/1266/

[trendmkr]

Amgen is Targeting a Blockbuster SOC Upheaval in Multiple Myeloma

http://marketexclusive.com/amgen-is-targeting-a-blockbuster-soc-upheaval-in-multiple-myeloma/1244/

[investorsa]

Good news for us: http://finance.yahoo.com/news/analysts-latest-recommendations-amgen-141159847.html

[Fibanotch]

thanx Dewwy

[DewDiligence]

I’ve heard suggestions that AMGN might consider spinning off the biosimilars business, but I doubt this will happen anytime soon and don’t think it would enhance shareholder value.

A stock split, which I also don’t expect, is a non-event.

[Fibanotch]

Do u care to elaborate on either?

[DewDiligence]

Are you asking about a split-up of AMGN into two companies... or a stock split?

[Fibanotch]

u think this thing will split , in the near future?

[DewDiligence]

FDA reviewing NVS’ 351(k) submission for Neulasta FoB: #msg-118583523.

[DewDiligence]

Musings on Humira’s patent estate: #msg-118144295.

[Sundance2]

Bunch of BS.. If AMGN had missed by even 1 penny it would have been slaughtered, down 10-15%.

AMGN hit a grand slam and gets less then 2% (FNBS).

[DewDiligence]

AMGN 3Q15 CC slides:

http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyMDQxNjR8Q2hpbGRJRD01OTkzNTA=

[Sundance2]

Blew every number out and AH is less then 2% gain? What a bunch of BS....

[Sundance2]

Not much activity on this board. Geeez no interest? Just jumped in when market tanks. Got it for 158.79.

Expecting good ER news tonight...Could be a nice little flip tomorrow.

[stocktrademan]

$AMGN recent news/filings

bullish optionable
ascending triangle breakout
good volume
macd crossup
macd making new highs
accumulation/distribution line climbing

## source: finance.yahoo.com

Fri, 31 Jul 2015 15:20:00 GMT ~ Amgen Stock Hits High As Street Eyes Growth Drivers


read full: http://news.investors.com/073115-764448-amgn-stock-gets-price-target-increases-after-q2-earnings.htm?ven=yahoocp&src=aurlled&ven=yahoo
*********************************************************

Fri, 31 Jul 2015 15:02:00 GMT ~ This is Why Amgen is Soaring


read full: http://blogs.barrons.com/stockstowatchtoday/2015/07/31/this-is-why-amgen-is-soaring/?mod=yahoobarrons&ru=yahoo
*********************************************************

Fri, 31 Jul 2015 13:42:00 GMT ~ Amgen (AMGN) Earnings Report: Q2 2015 Conference Call Transcript


read full: http://www.thestreet.com/story/13239684/1/amgen-amgn-earnings-report-q2-2015-conference-call-transcript.html?puc=yahoo&cm_ven=YAHOO
*********************************************************

Fri, 31 Jul 2015 13:21:01 GMT ~ Amgen Beats on Q2 Earnings & Revenues, Raises Outlook - Analyst Blog


read full: http://finance.yahoo.com/news/amgen-beats-q2-earnings-revenues-132101216.html
*********************************************************

Fri, 31 Jul 2015 13:01:02 GMT ~ Exxon Mobil profit drop; LinkedIn growth; Royal Caribbean sails higher


read full: http://finance.yahoo.com/news/exxon-mobil-profit-drop--linkedin-growth--royal-caribbean-sails-higher-130104276.html
*********************************************************

$AMGN charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$AMGN company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/AMGN/company-info
Ticker: $AMGN
OTC Market Place: Not Available
CIK code: 0000318154
Company name: Amgen Inc.
Company website: http://www.Amgen.com
Incorporated In: DE, USA

$AMGN share structure

## source: otcmarkets.com

Market Value: $130,539,969,872 a/o Jul 30, 2015
Shares Outstanding: 760,323,664 a/o Apr 20, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001

$AMGN extra dd links

Company name: Amgen Inc.
Company website: http://www.Amgen.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AMGN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AMGN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AMGN+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AMGN/news - http://finance.yahoo.com/q/h?s=AMGN+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AMGN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AMGN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AMGN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AMGN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Amgen+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Amgen+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Amgen+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.Amgen.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.Amgen.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.Amgen.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AMGN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000318154&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AMGN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AMGN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AMGN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AMGN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AMGN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AMGN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AMGN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AMGN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AMGN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AMGN+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AMGN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AMGN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AMGN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AMGN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AMGN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AMGN/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AMGN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AMGN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AMGN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AMGN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AMGN



$AMGN DD Notes ~ http://www.ddnotesmaker.com/AMGN

[investorsa]

Amgen Announces 2015 Third Quarter Dividend
PR Newswire Amgen

THOUSAND OAKS, Calif., July 28, 2015 /PRNewswire/ -- Amgen (AMGN) announced that its Board of Directors today declared a $0.79 per share dividend for the third quarter of 2015. The dividend will be paid on Sept. 8, 2015, to all stockholders of record as of the close of business on Aug. 17, 20

[DewDiligence]

Zarxio (Neupogen FoB) update: #msg-115571193.

[investorsa]

Still priced low: http://247wallst.com/healthcare-business/2015/07/20/4-large-cap-biotech-stocks-to-buy-before-earnings/